<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR144">
 <label>144.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Firempong</surname>
    <given-names>CK</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>X</given-names>
   </name>
  </person-group>
  <article-title>Enhanced solubility and bioavailability of naringenin via liposomal nanoformulation: preparation and in vitro and in vivo evaluations</article-title>
  <source>AAPS PharmSciTech</source>
  <year>2017</year>
  <volume>18</volume>
  <issue>3</issue>
  <fpage>586</fpage>
  <lpage>594</lpage>
  <pub-id pub-id-type="doi">10.1208/s12249-016-0537-8</pub-id>
  <?supplied-pmid 27151135?>
  <pub-id pub-id-type="pmid">27151135</pub-id>
 </element-citation>
</ref>
